Search Results 491-500 of 21329 for Inhibition
Nintedanib belongs to the group of drugs called tyrosine kinase inhibitors. This medicine is available only with your doctor's prescription. This product is ...
Immune checkpoint inhibitors. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors. Accessed ...
... inhibitor, applied either as monotherapy or in combination with other therapies as treatment for unresectable or metastatic cutaneous melanoma * Patients ...
The experimental drug, A939572, is a targeted inhibitor of SCD1 protein. "We found it to be incredibly specific to cancer cells in laboratory mice treated ...
PARP inhibitors block the action of enzymes in the cancer cells that help repair breaks in the DNA. These targeted therapy medicines work best in people with ...
Identifying an enzyme that regulates DNA repair; Identifying subsets of women who do not benefit from cancer drugs called aromatase inhibitors; Identifying ...
Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products. Exp Hematol. 2004 Apr; 32(4):365 ...
The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients ...
... inhibition significantly decreased glucose absorption. Importantly, we observed that enteroids from post-BS non-obese patients exhibited low dietary glucose ...
Irritable bowel syndrome — a group of symptoms that affect the stomach and intestines. Medications used to treat heartburn, such as proton pump inhibitors and H ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.